fda - Search News

News

FDA Plans To Use AI To Speed Up Scientific Review

US FDA launches AI tool to reduce time taken for scientific reviews

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews.

Forbes · 12m

The Prompt: FDA Plans To Use AI To Speed Up Scientific Review

Academic journals and scientific websites are being swamped by bots scraping hundreds of millions of documents and photographs to train generative AI models, accord

Engadget · 6h

The FDA rolls out its own AI to speed up clinical reviews and scientific evaluations

The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to investigations. Sure, we're living in a time of widespread disinformation and pushbacks against science, but why not rush things through with AI?

Tomato, FDA

USA TODAY on MSN · 2h

Tomatoes sold in 3 states now labeled deadly by FDA

Williams Farms Repack issued a recall for the tomatoes, the FDA announced last month. It's now labeled deadly.

NBC News on MSN · 3h

Tomato recall affecting 3 states elevated to risk of death by FDA

A tomato recall due to risk of salmonella contamination has been elevated by the U.S. Food and Drug Administration to its highest warning level. The FDA marked the tomato recall affecting three states as Class I,

People on MSN · 1h

FDA Warns That Tomatoes Sold in These 3 States Could Cause Serious Illness or 'Death'

Tomatoes sold in three southern states have been recalled due to possible salmonella contamination that could cause death, the Food and Drug Administration announced on May 28.

FDA approves Moderna’s next-generation COVID-19 vaccine

CBS News · 1d

New Moderna COVID-19 vaccine approved by FDA for adults 65 and older

The FDA approved a new Moderna COVID-19 vaccine for adults 65 and older.

MarketWatch · 1d

Moderna Shares Rise on FDA Approval of Covid-19 Vaccine

Moderna shares were up 4.9% in premarket trading after the Food and Drug Administration approved its newest Covid-19 vaccine over the weekend. Shares were trading around $27.85. The stock is down 36% on the year.

NBC News on MSN · 1d

FDA grants limited approval to new Covid vaccine from Moderna

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 and older, as well as people ages 12 to 64 with at least one medical condition that increases their risk for severe Covid.

1hon MSN

FDA approves first AI tool to predict breast cancer risk

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

FDA’s early AI debut sparks questions

The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...

Fierce Biotech3h

FDA, facing 4% budget cut, launches generative AI tool Elsa a month ahead of schedule

The FDA may be facing a 4% cut to its overall budget courtesy of the Trump administration, but that hasn’t stopped the agency ...

NBC Los Angeles54m

Kennedy orders FDA to review ingredients in baby formula. What parents should know

The FDA’s review will include increased testing for heavy metals and other contaminants, as well as a review of nutrients.

Nextgov2h

FDA unveils ‘Elsa’ generative AI tool for staff

Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...

2hon MSN

FDA commissioner commits to review of abortion pill

The Food and Drug Administration will conduct a review of the abortion pill mifepristone following intense pressure from Sen.

Targeted Oncology2h

FDA Grants Priority Review to NDA of Ziftomenib in NPM1-Mutant AML

If approved, ziftomenib could be the first FDA-approved Menin inhibitor for relapsed/refractory acute myeloid leukemia with ...

STAT5h

Pharmalittle: We’re reading about a FDA AI tool, mRNA as a political reject, and more

The FDA rolled out a generative AI tool for speeding regulatory reviews, announcing its launch nearly a month ahead of a June ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

FDA Plans To Use AI To Speed Up Scientific Review

Tomato, FDA

FDA approves Moderna’s next-generation COVID-19 vaccine

Related topics